Matches in SemOpenAlex for { <https://semopenalex.org/work/W1992043006> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W1992043006 endingPage "226" @default.
- W1992043006 startingPage "223" @default.
- W1992043006 abstract "Le terme « d’intolérance à l’aspirine et aux AINS » regroupe plusieurs phénotypes d’hypersensibilité : l’asthme intolérant à l’aspirine, l’urticaire chronique exacerbée par la prise d’aspirine ou d’AINS et le syndrome d’intolérance multiple aux AINS. Le point commun entre ces différents phénotypes est le mécanisme physiopathologique d’hypersensibilité qui est non immunologique, mais pharmacologique, lié à l’inhibition de COX-1. Cependant, les seuils de réactivité aux doses d’aspirine sont variables selon le phénotype considéré et la prise en charge diagnostique et thérapeutique doivent par conséquent être adaptées à la présentation clinique. Dans la majorité des cas, la réintroduction d’aspirine à doses anti-agrégantes est possible, soit d’emblée lors d’un test de provocation orale, soit sous forme de désensibilisation y compris en situation urgente. The term “NSAIDs and aspirin hypersensitivity” includes different phenotypes of hypersensitivity, namely aspirin-exacerbated respiratory disease, chronic urticaria exacerbated by aspirin or NSAIDs, and NSAID-induced urticaria/angioedema. The common point between these different phenotypes is a pathophysiologic mechanism which is not immunologic but pharmacologic, related to inhibition of COX-1. However, the threshold of reactivity to doses of aspirin varies according to the phenotype of the patient being considered, so the diagnosis and management must be adjusted to the clinical presentation. In the majority of cases, re-introduction of platelet-inhibitory doses of aspirin is possible, either starting with an oral provocation test or using a desensitization protocol, which is possible in emergency situations." @default.
- W1992043006 created "2016-06-24" @default.
- W1992043006 creator A5089974163 @default.
- W1992043006 date "2014-04-01" @default.
- W1992043006 modified "2023-10-01" @default.
- W1992043006 title "Un intolérant aux AINS peut-il prendre de l’aspirine à doses anti-agrégantes ?" @default.
- W1992043006 cites W1543164553 @default.
- W1992043006 cites W1975760990 @default.
- W1992043006 cites W1975857678 @default.
- W1992043006 cites W1984854386 @default.
- W1992043006 cites W2005427839 @default.
- W1992043006 cites W2023577096 @default.
- W1992043006 cites W2041983823 @default.
- W1992043006 cites W2074775012 @default.
- W1992043006 cites W2080970433 @default.
- W1992043006 cites W2086842326 @default.
- W1992043006 cites W2088356103 @default.
- W1992043006 cites W2091553554 @default.
- W1992043006 cites W2113648085 @default.
- W1992043006 cites W2117458235 @default.
- W1992043006 cites W2119753383 @default.
- W1992043006 cites W2129271442 @default.
- W1992043006 cites W2131296354 @default.
- W1992043006 cites W2142203155 @default.
- W1992043006 cites W2154145582 @default.
- W1992043006 cites W139988548 @default.
- W1992043006 doi "https://doi.org/10.1016/j.reval.2014.01.027" @default.
- W1992043006 hasPublicationYear "2014" @default.
- W1992043006 type Work @default.
- W1992043006 sameAs 1992043006 @default.
- W1992043006 citedByCount "2" @default.
- W1992043006 countsByYear W19920430062016 @default.
- W1992043006 countsByYear W19920430062017 @default.
- W1992043006 crossrefType "journal-article" @default.
- W1992043006 hasAuthorship W1992043006A5089974163 @default.
- W1992043006 hasConcept C110586980 @default.
- W1992043006 hasConcept C126322002 @default.
- W1992043006 hasConcept C142724271 @default.
- W1992043006 hasConcept C185592680 @default.
- W1992043006 hasConcept C202751555 @default.
- W1992043006 hasConcept C203014093 @default.
- W1992043006 hasConcept C204787440 @default.
- W1992043006 hasConcept C2776980637 @default.
- W1992043006 hasConcept C2777628954 @default.
- W1992043006 hasConcept C2777995640 @default.
- W1992043006 hasConcept C2909020919 @default.
- W1992043006 hasConcept C55493867 @default.
- W1992043006 hasConcept C71924100 @default.
- W1992043006 hasConcept C98274493 @default.
- W1992043006 hasConceptScore W1992043006C110586980 @default.
- W1992043006 hasConceptScore W1992043006C126322002 @default.
- W1992043006 hasConceptScore W1992043006C142724271 @default.
- W1992043006 hasConceptScore W1992043006C185592680 @default.
- W1992043006 hasConceptScore W1992043006C202751555 @default.
- W1992043006 hasConceptScore W1992043006C203014093 @default.
- W1992043006 hasConceptScore W1992043006C204787440 @default.
- W1992043006 hasConceptScore W1992043006C2776980637 @default.
- W1992043006 hasConceptScore W1992043006C2777628954 @default.
- W1992043006 hasConceptScore W1992043006C2777995640 @default.
- W1992043006 hasConceptScore W1992043006C2909020919 @default.
- W1992043006 hasConceptScore W1992043006C55493867 @default.
- W1992043006 hasConceptScore W1992043006C71924100 @default.
- W1992043006 hasConceptScore W1992043006C98274493 @default.
- W1992043006 hasIssue "3" @default.
- W1992043006 hasLocation W19920430061 @default.
- W1992043006 hasOpenAccess W1992043006 @default.
- W1992043006 hasPrimaryLocation W19920430061 @default.
- W1992043006 hasRelatedWork W1984088887 @default.
- W1992043006 hasRelatedWork W2007556296 @default.
- W1992043006 hasRelatedWork W2014919180 @default.
- W1992043006 hasRelatedWork W2049199968 @default.
- W1992043006 hasRelatedWork W2056632106 @default.
- W1992043006 hasRelatedWork W2158692822 @default.
- W1992043006 hasRelatedWork W2410025450 @default.
- W1992043006 hasRelatedWork W2422019296 @default.
- W1992043006 hasRelatedWork W43774587 @default.
- W1992043006 hasRelatedWork W2158950767 @default.
- W1992043006 hasVolume "54" @default.
- W1992043006 isParatext "false" @default.
- W1992043006 isRetracted "false" @default.
- W1992043006 magId "1992043006" @default.
- W1992043006 workType "article" @default.